chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 10.0
Sex: M
Vaccine: FLUN4
Symptoms: Influenza A virus test positive
Clinical narrative: A report has been received from a Health Professional concerning a patient, Male subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on 04-Oct-2013. The patient experienced tested positive for strain A flu which started on 24-Feb-2014. The patient recovered from the event of tested positive for strain A flu on an unspecified date. The report was considered to be non-serious. Summary of follow-up information received by AstraZeneca/MedImmune on 17-Apr-2014 from a health professional: Vaccine start date, expiry date added. Patient details added.
Age: 5.0
Sex: M
Vaccine: FLUN4
Symptoms: Cough, Influenza virus test positive, Pyrexia
Clinical narrative: A spontaneous report has been received from a Physician concerning a 05 years male patient. The physician reported for three patients. No information regarding relevant medical history, concomitant disease or concomitant medication was provided. The patient was receiving FLUMIST (Intranasal) started during Sep-2013. Patient developed fever, cough. They tested positive for Influenza. Physician did not know the date each patient developed the symptoms, but her said it was 3 months after receiving FLUMIST. Patient was treated with TAMIFLU and recovered. The reporter considered the event influenza as non-serious.
Age: 5.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning a 5 year old, female subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on an unknown date. It was reported that patient had received expired FLUMIST QUADRIVALENT on 28-Mar-2014. The outcome of the event of received expired FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious.
Age: 5.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning a 5 year old, female subject, who had been receiving Nasal FLUMIST. FLUMIST started on 04-Apr-2014. The healthcare professional reported that they inadvertently administered expired FLUMIST to a patient 24-March-2014 which started on 04-Apr-2014. The outcome of the event of we inadvertently administered expired FLUMIST to a patient is unknown. The report was considered to be non-serious.
Sex: F
Vaccine: FLUN4
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: A report has been received from a Health Professional concerning an adult, female subject, who had been receiving FLUMIST (Intranasal). FLUMIST (Intranasal) started on an unknown date. It was reported that a nurse, who was over 49 years old, was administered FLUMIST. The outcome of the event of ADMINISTERED TO 49 YEAR OLD was unknown. The report was considered to be non-serious. Summary of insignificant follow-up information received by AstraZeneca/MedImmune on 25-Apr-2014 from Health Professional: Reporter information updated.
Sex: U
Vaccine: FLUN4
Symptoms: Epistaxis, Immediate post-injection reaction
Clinical narrative: A report has been received from a physician via Medical representative concerning one of two patients whose other details were not reported. Medical history, concurrent diseases and concomitant medications of the patient were not provided. On an unknown date, nasal FLUMIST QUADRIVALENT was started. Therapy dates, indication, dosing and frequency were not reported. The patient experienced nosebleeds immediately after receiving FLUMIST QUADRIVALENT. They inquired if it was normal. The action taken with the suspected product was unknown. The outcome of the event of nosebleed was unknown. The report was considered to be non-serious by the reporter. Corrected report on 10-Apr-2014: full narrative added.
Age: 21.0
Sex: F
Vaccine: FLUN4
Symptoms: Asthenia, Back pain, Bone pain, Chest discomfort, Dyspnoea
Clinical narrative: A consumer report has been received. The report concerns a patient, female consumer, who had been receiving nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on an unknown date. The patient experienced pain in back on other bones, pressure and tightness in chest, trouble breathing, pain in ribs, felt like I have fever, WBC count slightly high, weak and tired. The outcome os the event of pain in back on other bones, pressure and tightness in chest, trouble breathing, pain in ribs, felt like I have fever, WBC count slightly high, weak and tired is unknown. The report was considered to be non-serious.
Age: 21.0
Sex: F
Vaccine: FLUN4
Symptoms: Fatigue, Musculoskeletal chest pain, Pyrexia, White blood cell count increased
Clinical narrative: A consumer report has been received. The report concerns a patient, female consumer, who had been receiving nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on an unknown date. The patient experienced pain in back on other bones, pressure and tightness in chest, trouble breathing, pain in ribs, felt like I have fever, WBC count slightly high, weak and tired. The outcome os the event of pain in back on other bones, pressure and tightness in chest, trouble breathing, pain in ribs, felt like I have fever, WBC count slightly high, weak and tired is unknown. The report was considered to be non-serious.
Age: 5.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning a 5 year old, male subject, who had been receiving nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on 24-Mar-2014. It was reported that the patient had administered expired FLUMIST QUADRIVALENT which started on 25-Mar-2014. The outcome of the event of administered expired FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious.
Age: 4.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A spontaneous report was received from a Health Professional concerning a 4 year old, male subject, who had been receiving Nasal FLUMIST QUADRIVALENT started on 08-Apr-2014. The patient had been given expired FLUMIST QUADRIVALENT administered/inadvertent administration of expired FLUMIST QUADRIVALENT which started on 08-Apr-2014. The outcome of the event of expired FLUMIST QUADRIVALENT/inadvertent administration of expired FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious.
Age: 8.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired drug administered, No adverse event
Clinical narrative: A report has been received from a Health Professional concerning an 8 year old, male subject, who had been receiving FLUMIST (Intranasal). FLUMIST (Intranasal) started on 25-Mar-2014. The Medical Assistant reported that patients received expired FLUMIST on 25-Mar-2014. No symptoms reported. The outcome of the event of ADMINISTERED EXPIRED FLUMIST is unknown. The report was considered to be non-serious by reporter.
Age: 16.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning a 16 year old, female subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT (Intranasal) started on 14-Apr-2014. Health Professional reported that patient received expired FLUMIST QUADRIVALENT (Expiry date: 07-Apr-2014) on 14-Apr-2014. The outcome of the event of expired FLUMIST QUADRIVALENT administered is unknown. The report was considered to be non-serious. Corrected Report 19-May-2014: Key ingredient of the suspect drug changed to Q/LAIV.
Age: 8.0
Sex: F
Vaccine: FLUN4
Symptoms: Cough, Influenza virus test positive, Pyrexia
Clinical narrative: A report has been received from a Physician via Medical representative concerning an 8 years old, female patient. No information regarding relevant history, concomitant disease and concomitant medications were provided. The patient developed fever, cough. They tested positive for Influenza. Doctor did not know the date each patient developed the symptoms, but her said it was 3 months after receiving FLUMIST (Intranasal) in Oct-2013. Patient were treated with TAMIFLU and recovered. The reporter considered the event to be non-serious.
Age: 50.0
Sex: M
Vaccine: FLUN4
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: A spontaneous report has been received from a pharmacist concerning a 50 year old, male subject, who had been receiving nasal FLUMIST QUADRIVALENT. The patient's medical history included high blood pressure. Concomitant medications included Lisinopril. FLUMIST QUADRIVALENT started on 22-Nov-2013. The patient reported the following adverse event administered FLUMIST QUADRIVALENT to a 50 yo which started on 21-Nov-2013. The outcome of the event of administered FLUMIST QUADRIVALENT to a 50 yo is unknown. The report was considered to be non-serious by the reporter.
Age: 7.0
Sex: M
Vaccine: FLUN4
Symptoms: Cough, Influenza virus test positive, Pyrexia
Clinical narrative: A report has been received from a Physician via Medical representative concerning an 7 years old, male patient. No information regarding relevant history, concomitant disease and concomitant medications were provided. The patient developed fever, cough. They tested positive for Influenza. Doctor did not know the date each patient developed the symptoms, but her said it was 3 months after receiving nasal FLUMIST QUAD in Oct-2013. Patient were treated with TAMIFLU and recovered. The reporter considered the event to be non-serious.
Age: 0.87
Sex: F
Vaccine: FLUN4
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: A report has been received from a Health Professional concerning a 10 month old, female subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT (Intranasal) started on 04-Mar-2014. It was reported that they gave FLUMIST QUADRIVALENT to a 10 month old. FLUMIST QUADRIVALENT (Intranasal) was discontinued on 04-Mar-2014. The outcome of the event of gave FLUMIST QUADRIVALENT to a 10 month old is unknown. The report was considered to be non-serious.
Sex: F
Vaccine: FLUN4
Symptoms: Influenza
Clinical narrative: A report has been received from a female physician via medical representative concerning herself. The age of the patient was unknown. Patient's relevant history and concomitant disease were not reported. Patient's concomitant medication was not provided. The reporter reported that the patient (who was a physician) received FLUMIST in Sep-13 and was diagnosed with the flu in May-14. Patient was down for 12 days. The outcome of the event of diagnosed with influenza was unknown. The reporter assessed the event of diagnosed with influenza to be non-serious.
Age: 2.0
Sex: U
Vaccine: FLUN4
Symptoms: Influenza, Influenza virus test positive
Clinical narrative: A report had been received from a Health Professional (Medical Assistant) via medical representative concerning a 2 year old, patient of unknown gender. No information regarding medical history, concomitant disease or concomitant medication was provided. Medical Assistant reported that the patient came into their family practice last year and was tested for flu. Patient had gotten FLUMIST QUADRIVALENT (intranasal) two weeks earlier and gave flu to the family. The FLUMIST QUADRIVALENT was given in another office. Action taken with FLUMIST QUADRIVALENT and outcome of the event was unknown. The report was considered to be non-serious by the reporter.
Sex: U
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a physician concerning a patient of unknown gender. The patient started receiving nasal FLUMIST QUADRIVALENT on an unknown date. During Jan-2014, the patient received expired FLUMIST. The outcome of the event of received expired FLUMIST was unknown. The event of received expired FLUMIST was considered to be non-serious by the reporter.
Age: 6.0
Sex: M
Vaccine: FLUN4, FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning a 6 year old, male subject, who had been receiving FLUMIST (Intranasal). FLUMIST (Intranasal) started on 14-Jan-2014. The health professional stated that patient was administered expired dose of FLUMIST which started on 14-Jan-2014. The outcome of the event of ADMINISTRATION OF EXPIRED DOSE is unknown. The report was considered to be non-serious.
Age: 6.0
Sex: M
Vaccine: FLUN4, FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from Novartis Pharmaceutical via a Health Professional concerning a 6 year old, male subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on 14-Jan-2014. It was reported by Health Professional that patient was received expired FLUMIST QUADRIVALENT (expiry date: 13-Jan-2014) which started on 14-Jan-2014. The outcome of the event of administered expired FLUMIST is unknown. The report was considered to be non-serious. Summary of follow-up information received by AstraZeneca/MedImmune on 24-Mar-2014 from a health professional: Reporter information updated.
Age: 9.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning a 9 year old, female subject, who had been receiving FLUMIST (Intranasal). FLUMIST (Intranasal) started on 08-Apr-2014. Health Professional reported the patient received expired FLUMIST (expiry date: 07-Apr-2014) on 08-Apr-2014. The outcome of the event of EXPIRED FLUMIST ADMINISTERED is unknown. The report was considered to be non-serious.
Sex: M
Vaccine: FLUN4
Symptoms: Influenza
Clinical narrative: A spontaneous report has been received from a Health Professional concerning a male patient of age 20 to 30 years. No information regarding relevant medical history, concomitant disease or concomitant medication was provided. The patient was receiving Nasal FLUMIST QUADRIVALENT started during Aug-2013. Patient received FLUMIST in Aug-2013 and was diagnosed with the flu 01-Jan-2014 and 28-Feb-2014. The patient recovered from the event of diagnosed twice with flu was unknown. The reporter considered the event diagnosed twice with flu as non-serious.
Sex: F
Vaccine: FLUN4
Symptoms: Influenza
Clinical narrative: A report has been received from Health Professional concerning a female patient. No information regarding relevant history, concomitant disease and concomitant medications were provided. The patient had been received nasal FLUMIST (intranasal) on an unknown date. Prescriber took FLUMIST herself and administered it to her daughter and they both got the flu in Dec-2013. The outcome of the event of flu was unknown. The reporter considered the event to be non-serious.
Sex: F
Vaccine: FLUN4
Symptoms: Influenza A virus test positive, Pneumonia
Clinical narrative: A report has been received from a health professional (nurse practitioner) via medical representative concerning a female patient with unknown age. Relevant history and concomitant medication was not reported. During Oct-2013 the patient started therapy with nasal FLUMIST QUADRIVALENT for unknown indication with unknown dose and frequency. During Dec-2013 a nurse practitioner got FLUMIST QUADRIVALENT then tested positive for flu A and also had pneumonia. Laboratory values are available. The action taken of FLUMIST QUADRIVALENT was unknown. The outcome of the event of Influenza A and pneumonia were unknown. The report was considered to be non-serious by the reporter.
Age: 7.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired drug administered, No adverse event
Clinical narrative: A report has been received from a Health Professional concerning a 7 year old, Female subject, who had been receiving Nasal FLUMIST (INTRANASAL) started on 08-Apr-2014. The patient received expired FLUMIST on 08-Apr-2014. The reporter stated that several FLUMIST doses were entered into their system as expiring on 7/4 (04-Jul-2014) instead of 4/7 (07-Apr-2014). There was an error in entering the expiration dates into their system. That's why there was an administration error. No adverse reaction reported. The patient experienced EXPIRED FLUMIST QUADRIVALENT ADMINISTERED. The outcome of the event of EXPIRED FLUMIST QUADRIVALENT ADMINISTERED is unknown. The report was considered to be non-serious by reporter.
Age: 4.0
Sex: M
Vaccine: FLUN4
Symptoms: Pyrexia
Clinical narrative: A report has been received from a Health Professional concerning a 4 year old, male subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT (Intranasal) started during Sep-2013. The patient experienced fever 102 degrees Fahrenheit. The outcome of the event of fever of 102 degrees Fahrenheit is unknown. The report was considered to be non-serious.
Age: 3.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning a 3 year old, male subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on 11-Mar-2014. It was reported by Health Professional that patient received expired FLUMIST QUADRIVALENT (exp. date 10-Mar-2014) which started on 11-Mar-2014. The outcome of the event of administered expired FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious.
Sex: F
Vaccine: FLUN4
Symptoms: Influenza
Clinical narrative: A report has been received from Health Professional, concerning a female patient. No information regarding relevant history, concomitant disease and concomitant medications were provided. The patient had been received nasal FLUMIST QUADRIVALENT on an unknown date. Prescriber took FLUMIST QUADRIVALENT herself and administered it to her daughter and they both got the flu in Dec-2013. This case concerns the daughter. The outcome of the event of flu was unknown. The reporter considered the event to be non-serious.
Sex: U
Vaccine: FLUN4
Symptoms: Influenza A virus test positive
Clinical narrative: A report has been received from a Physician concerning multiple patients of unknown gender, who had been receiving FLUMIST (Intranasal). FLUMIST (Intranasal) started on an unknown date. The patient experienced ONE TO TEN PATIENTS RECEIVED FLUMIST AND TESTED POSITIVE FOR INFLUENZA A. The outcome of the event of ONE TO TEN PATIENTS RECEIVED FLUMIST AND TESTED POSITIVE FOR INFLUENZA A is unknown. The report was considered to be non-serious.
Age: 9.0
Sex: F
Vaccine: FLUN4
Symptoms: Influenza, Influenza A virus test positive
Clinical narrative: A report from a nurse concerns a 9 year old female. Relevant medical history and concomitant diseases were unknown. During Oct-2013, patient received nasal FLUMIST QUADRIVALENT. During Dec-2013, the patient was tested positive for influenza A. Action taken with FLUMIST QUADRIVALENT was unknown. At the time of reporting the outcome of the event of influenza A was unknown. The report was considered to be non-serious by the reporter.
Sex: U
Vaccine: FLUN4
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: A report has been received from a Pharmacist concerning an adult, subject of unknown gender, who had been receiving Nasal FLUMIST QUADRIVALENT. The patient was over the age of 49 years, it is considered as off label use; consumer who is over the age of 49 years received the intranasal vaccine. FLUMIST QUADRIVALENT (Intranasal) started on an unknown date. The outcome of the event of off label use; consumer who is over the age of 49 years received the intranasal vaccine is unknown. The report was considered to be non-serious by the reporter.
Age: 51.0
Sex: M
Vaccine: FLUN4
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: A report has been received from a Health Professional concerning a 51 year old male patient. The patient's concurrent disease (s) included TOBACCO ABUSE and VITAMIN D DEFICIENCY. Concomitant medications included ERGOCALCIFEROL. On 19-Feb-2014, the patient received nasal FLUMIST (INTRANASAL). On 19-Feb-2014, the patient received INADVERTENTLY FLUMIST QUADRIVALENT OVER 49 YEARS of age. The outcome of the event of INADVERTENTLY GAVE FLUMIST QUADRIVALENT TO PATIENT OVER 49 YEARS is unknown. The report was considered to be non-serious by the company physician.
Age: 50.0
Sex: F
Vaccine: FLUN4
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: A report has been received from a Pharmacist concerning a 50 year old, female subject, who had been receiving FLUMIST Intranasal) FLUMIST (Intranasal) started on an unknown date. It was reported by the pharmacist that on 17-Oct-2013, they administered FLUMIST to the patient who is 50 years old. The patient did not experience any adverse symptoms. The outcome of the event of INADVERTENTLY ADMINISTERED FLUMIST is unknown. The report was considered to be non-serious by reporter. Summary of insignificant follow-up information received by AstraZeneca/MedImmune on 27-Feb-2014 from pharmacist: Start date for the suspect product FLUMIST added. Form completed date updated. Narrative updated. Corrected report on 20-Apr-2014: Patient initials added. Event onset date added. Reporter information corrected. Positive rechallenge, dechallenge information corrected.
Age: 52.0
Sex: M
Vaccine: FLUN4
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: A report has been received from a Pharmacist concerning a 52 year old, male subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT (Intranasal) started on an unknown date. The reporter stated accidentally gave FLUMIST to a 52 year old patient which started on 09-Jan-2014. The reporter stated accidentally gave FLUMIST to a 52 year old patient is unknown. The report was considered to be non-serious by the reporter. Corrected report 22-Apr-2014: Coding of the event was corrected from wrong drug administered to drug administered to patient of inappropriate age. Narrative updated.
Sex: U
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning, subject of unknown gender, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT (Intranasal) started on an unknown date. It was reported that three patients received expired FLUMIST. The outcome of the event of three patients received expired FLUMIST is unknown. The report was considered to be non-serious.
Age: 5.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning a 5 year old, male subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT (Intranasal) started on an unknown date. The patient received expired product which started on 06-May-2014. The outcome of the event of administration of expired product is unknown. The report was considered to be non-serious by reporter.
Age: 8.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning an 8 year old, female subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT (Intranasal) started on 14-Jan-2014. The patient was administered expired FLUMIST to two patients which started on 14-Jan-2014. FLUMIST QUADRIVALENT (Intranasal) was discontinued on 14-Jan-2014. The outcome of the event of administered expired FLUMIST to two patients is unknown. The report was considered to be non-serious. Corrected report 18-Mar-2014: Form completed date was updated. Summary of follow-up information received by AstraZeneca/MedImmune on 24-Mar-2014 from a Health Professional: Lot no and Expiry date was added. Form completed date was updated.
Sex: U
Vaccine: FLUN3, FLUN4
Symptoms: Wheezing
Clinical narrative: A report has been received from a Health Professional concerning elementary patients of unknown age. The relevant history and concomitant drugs of patient were not reported. The patient had been receiving nasal FLUMIST (intranasal) and nasal FLUMIST quadrivalent (intranasal) started on an unknown date. The nurse reported that there had been at least 5 elementary aged patients in the past two years and had come into the office to get treated for wheezing after having received the FLUMIST. The outcome of the event of wheezing was unknown. The reporter considered event of wheezing to be non-serious.
Sex: M
Vaccine: FLUN4
Symptoms: Influenza virus test positive
Clinical narrative: A report has been received from a physician via medical rep, concerning an adult male patient. No relevant history, concomitant disease or concomitant medications of the patient were reported. The patient had received nasal FLUMIST (intranasal). It was reported that the spouse of the physician tested positive for flu. Action taken with influenza virus vaccine, intranasal was not applicable. The outcome of the event of tested positive for flu was unknown. The reporter assessed the event of tested positive for flu to be non-serious.
Age: 14.0
Sex: M
Vaccine: FLUN4
Symptoms: Influenza virus test positive
Clinical narrative: A spontaneous report has been received from a Health Professional concerning a 14 year old, male patient among the four patients. No information regarding medical history, concomitant disease or concomitant medication on was provided. The patient was receiving nasal FLUMIST QUADRIVALENT started during Oct-2013. The reporter stated that a total of four of their patients received FLUMIST and later tested positive for the flu which started on 15-Dec-2013. The outcome of the event of tested positive for flu was unknown. The reporter considered the event tested positive for flu as non-serious.
Age: 15.0
Sex: M
Vaccine: FLUN4
Symptoms: Influenza virus test positive
Clinical narrative: A report had been received from a health Professional concerning a 15 years old male patient. No information regarding relevant medical history, concomitant disease or concomitant medication was provided. The patient had received nasal FLUMIST QUADRIVALENT started during Oct-2013. It was reported that a total of four of their patients received FLUMIST and later tested positive for the flu which started on 15-Dec-2013. Action taken with FLUMIST QUADRIVALENT was unknown. The outcome of the event of tested positive for flu was unknown. The reporter assessed the event of tested positive for flu to be non-serious.
Age: 17.0
Sex: M
Vaccine: FLUN4
Symptoms: Influenza A virus test positive
Clinical narrative: A report has been received from a Physician concerning a 17 year old, male subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT (Intranasal) started during Oct-2013. It was reported that the patient had tested positive for H1N1 which started on 15-Dec-2013. The outcome of the event of tested positive for H1N1 is unknown. The report was considered to be non-serious.
Sex: F
Vaccine: FLUN4
Symptoms: Exposure during pregnancy, No adverse event
Clinical narrative: A report has been received from a Health Professional concerning, female patient, who had been receiving Nasal FLUMIST QUADRIVALENT (INTRANASAL). FLUMIST QUADRIVALENT (INTRANASAL) started on an unknown date. Nurse reported that the patient was pregnant inadvertently received FLUMIST on 27-Feb-2014. No symptoms to reported. The outcome of the event of ADMINISTRATION TO A PREGNANT FEMALE is unkonwn. The report was considered to be non-serious.
Sex: U
Vaccine: FLUN4
Symptoms: Epistaxis, Immediate post-injection reaction
Clinical narrative: A report has been received from a physician concerning a patient of unknown gender and age. Medical history of the patient was not reported. There was no information on the concomitant medication. The physician reported about two patients (this case related one of them) who experienced nosebleeds immediately after receiving FLUMIST (Intranasal). Action taken with FLUMIST and outcome of the event was unknown. The report was considered to be non-serious by the reporter.
Age: 59.0
Sex: F
Vaccine: FLUN4
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: A report has been received from a Health Professional concerning a 59 year old female patient. The patient's medical history included hypercholesterolemia, hypertension, osteopenia, allergic rhinitis and tobacco abuse. Concomitant medications included lisinopril, simvastatin, alendronate sodium, estrogens conjugated, medrogestone and azelastine hydrochloride. On 19-Feb-2014, the patient received nasal FLUMIST. On 19-Feb-2014, the patient received inadvertently FLUMIST QUADRIVALENT over 49 years of age. The outcome of the event of inadvertently gave FLUMIST QUADRIVALENT to patient over 49 years is unknown. The report was considered to be non-serious by the company physician.
Sex: U
Vaccine: FLUN4
Symptoms: Influenza, Vaccine breakthrough infection
Clinical narrative: A report has been received from a physician via medical rep, concerning multiple patients of unknown ages and genders. No relevant history, concomitant disease or concomitant medications of the patients were reported. The patients had received FLUMIST (Intranasal). It was reported that there were several breakthrough cases of Influenza. Action taken with influenza virus vaccine live, intranasal was unknown. The outcome of the event of several breakthrough cases of influenza was unknown. The reporter assessed the event of several breakthrough cases of influenza to be non-serious.
Age: 28.0
Sex: F
Vaccine: FLUN4
Symptoms: Drug administration error
Clinical narrative: A report has been received from a pharmacist concerning a 28 year old, female patient. No information regarding relevant history, concomitant disease and concomitant medications were provided. The patient received nasal FLUMIST QUADRIVALENT on 15-Feb-2014. The patient was administered entire dose of FLUMIST QUADRIVALENT in one nostril on 15-Feb-2014. The patient did not have any adverse events. The outcome of the event of administered entire ose of FLUMIST QUADRIVALENT in one nostril was unknown. The reporter considered the event to bee non-serious. Corrected report 06-May-2014. The case has been updated with full data due to KUR term additions for FLUMIST/Q/Laiv.
Age: 3.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning a 3 year old, female subject who had been receiving Nasal FLUMIST (INTRANASAL) started on 18-Feb-2014. The patient received expired FLUMIST on 18-Feb-2014. The outcome of the event of INADVERTENTLY GAVE EXPIRED FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious.
Sex: U
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Physician concerning, subject of unknown gender, who had been receiving FLUMIST (Intranasal). FLUMIST (Intranasal) started on an unknown date. Patient received expired FLUMIST. The patient experienced RECEIVED EXPIRED FLUMIST which started during 2014. The outcome of the event of RECEIVED of RECEIVED EXPIRED FLUMIST is unknown. The report was considered to be non-serious by the reporter.
Age: 52.0
Sex: F
Vaccine: FLUN4
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: A report has been received from a Pharmacist concerning a 52 year old, female subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT (Intranasal) started on 21-Nov-2013. One patient over 49 years received FLUMIST. The patient experienced patient over 49 years old received FLUMIST which started on 21-Nov-2013. The outcome of the event of patient over 49 years old received FLUMIST is unknown. The report was considered to be non-serious by the reporter.
Sex: U
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Physician concerning, subject of unknown gender, who had been receiving FLUMIST (Intranasal). FLUMIST (Intranasal) started on an unknown date. Expired drug administered. The patient experienced RECEIVED EXPIRED FLUMIST which started during 2014. The outcome of the event RECEIVED EXPIRED FLUMIST is unknown. The report was considered to be non-serious by the reporter.
Sex: U
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a physician concerning a patient of unknown gender, who had been receiving nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started during 2014. The patient received expired FLUMIST during 2014. The outcome of the event of received expired FLUMIST is unknown. The report was considered to be non-serious by the reporter.
Sex: U
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Physician concerning 11 patients. This case belongs to one of them. The patient of unknown gender, had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT (Intranasal) started on an unknown date. The patient received expired FLUMIST during 2014. The outcome of the event of received expired FLUMIST is unknown. The report was considered to be non-serious by the reporter.
Sex: U
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Physician concerning 11 subjects of unknown gender, who had been receiving FLUMIST (Intranasal). FLUMIST (Intranasal) started on an unknown date. The patients received expired FLUMIST during January or February 2014. The outcome of the event of RECEIVED EXPIRED FLUMIST is unknown. The report was considered to be non-serious by the reporter.
Sex: U
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Physician concerning 11 patients. This case belongs to one of them. The patient with unknown gender had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT (Intranasal) started on an unknown date. The patient received expired FLUMIST during 2014. The outcome of the event of received expired FLUMIST is unknown. The report was considered to be non-serious by the reporter.
Age: 14.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning a 14 year old, male subject, who had been receiving FLUMIST (Intranasal). FLUMIST (Intranasal) started on 24-Jan-2014. The patient experienced EXPIRED FLUMIST whish started on 24-Jan-2014. The outcome of the event of EXPIRED FLUMIST is unknown. The report was considered to be non-serious as per reporter.
Age: 10.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning a 10 year old, male subject, who had been receiving FLUMIST (Intranasal). FLUMIST (Intranasal) started on 24-Jan-2014. The outcome of the event of EXPIRED FLUMIST is unknown. The report was considered to be non-serious.
Age: 11.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning an 11 year old, female subject, who had been receiving Nasal FLUMIST QUADRIVALENT. The reporter reported for 17 patients who had inadvertently administered expired FLUMIST. FLUMIST QUADRIVALENT (Intranasal) started on 27-Jan-2014. It was reported that the patient was inadvertently administered expired FLUMIST which started on 27-Jan-2014. The outcome of the event of expired FLUMIST is unknown. The report was considered to be non-serious.
Age: 2.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning a 2 year old, female subject, who had been receiving FLUMIST (Intranasal). FLUMIST (Intranasal) started on 27-Jan-2014. It was reported that expired FLUMIST was inadvertently administered on 27-Jan-2014. The outcome of the event of INADVERTENTLY ADMINISTERED EXPIRED FLUIST is unknown. The report was considered to be non-serious.
Age: 7.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning a 7 year old, male subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT (Intranasal) started on 23-Jan-2014. The patient was administered expired FLUMIST on 23-Jan-2014. The outcome of the event of expired FLUMIST is unknown. The report was considered to be non-serious.
Age: 15.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning a 15 year old, male subject, who had been receiving Nasal FLUMIST QUADRIVALENT. This case was related to the one of the 17 patients who had administered the expired FLUMIST. FLUMIST QUADRIVALENT (Intranasal) started on 26-Jan-2014. It was reported that the expired FLUMIST was administered to the patient on 26-Jan-2014. Lot number BK2023. Expiry date 20-Jan-2014. The outcome of the event of expired FLUMIST is unknown. The report was considered to be non-serious.
Age: 13.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning a 13 year old, female subject, who had been receiving Nasal FLUMIST QUADRIVALENT. The reporter reported for 17 patients who had inadvertently administered expired FLUMIST. FLUMIST QUADRIVALENT (Intranasal) started on 27-Jan-2014. It was reported that the patient was inadvertently administered expired FLUMIST which started on 27-Jan-2014. The outcome of the event of expired FLUMIST is unknown. The report was considered to be non-serious.
Age: 9.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning a 9 year old, female subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT (Intranasal) started on 27-Jan-2014. The patient was administered expired FLUMIST on 27-Jan-2014. The outcome of the event of expired FLUMIST is unknown. The report was considered to be non-serious.
Sex: F
Vaccine: FLUN4
Symptoms: Influenza
Clinical narrative: A report has been received from a medical rep concerning a female patient. The patient's medical history and concomitant medications were not reported. On 31-Oct-2013, the patient started receiving treatment with nasal FLUMIST (Intranasal). On 11-Feb-2014 patient presented to the doctor's office with influenza A. Action taken with FLUMIST was unknown. The outcome of the event of influenza A was unknown. The report was considered to be non-serious by reporter.
Sex: U
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Pharmacist concerning, subject of unknown gender, who had been receiving FLUMIST (Intranasal). FLUMIST (Intranasal) started on an unknown date. The patient received EXPIRED FLUMIST on 12-Feb-2014. The outcome of the event of EXPIRED FLUMIST is unknown. The report was considered to be non-serious by the reporter.
Age: 8.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning an 8 year old, female subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT (Intranasal) started on 27-Jan-2014. The patient was administered expired FLUMIST on 27-Jan-2014. The outcome of the event of inadvertently administered expired FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious by the reporter.
Sex: U
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Physician concerning, subject of unknown gender, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT (Intranasal) started on an unknown date. The patient reported received expired FLUMIST which started during 2014. The outcome of the event of received expired FLUMIST is unknown. The report was considered to be non-serious by the reporter.
Sex: U
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Physician concerning 11 subjects of unknown gender, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT (Intranasal) started on an unknown date. The patients received expired FLUMIST during January or February 2014. The outcome of the event of received expired FLUMIST is unknown. The report was considered to be non-serious by the reporter.
Age: 11.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning an 11 year old, female subject, who had been receiving FLUMIST (Intranasal). FLUMIST (Intranasal) started on 27-Jan-2014. It was reported that patient was inadvertently administered expired FLUMIST on 27-Jan-2014. The outcome of the event of INADVERTENTLY ADMINISITERED EXPIRED FLUMIST is unknown. The report was considered to be non-serious.
Age: 8.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning an 8 year old, female subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT (Intranasal) started on 27-Jan-2014. The patient was inadvertently administered with expired FLUMIST QUADRIVALENT on 27-Jan-2014. The outcome of the event of inadvertently administered expired FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious.
Age: 7.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning a 7 year old, male subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT (Intranasal) started on 27-Jan-2014. It was reported that expired FLUMIST was inadvertently administered, which started on 27-Jan-2014. The outcome of the event of inadvertently administered expired FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious.
Age: 10.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning a 10 year old, female subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT (Intranasal) started on 27-Jan-2014. It was reported that patient was inadvertently administered expired FLUMIST QUADRIVALENT which started on 27-Jan-2014. The outcome of the event of inadvertently administered expired FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious.
Age: 5.0
Sex: F
Vaccine: FLUN4
Symptoms: Influenza, Influenza A virus test positive, Pneumonia, Pyrexia
Clinical narrative: A report has been received from a Physician concerning a 5 year old, female patient. No information regarding relevant history concomitant disease and concomitant medications were provided. The patient received FLUMIST (Intranasal) on an unknown date. Patient was seen in the office on 24-Oct-2013 with a fever and other flu symptoms, she tested positive for Flu A and was treated symptomatically. She was seen again on 06-Jan-2014 with flu symptoms with symptoms beginning 04-Jan-2014; she was treated symptomatically. The patient was seen again on 13-Jan-2014 and was diagnosed with pneumonia and was treated with Z-Pak. Patient was not hospitalized. She was recovered. The reporter considered the event of tested positive for Flu A to be non-serious. Event of pneumonia was identified and captured by the company physician as non-serious event. Corrected report 13-Feb-2014: the key ingredient of the suspect drug was corrected from FLUMIST to Q/LAIV. Drug as reported also corrected from FLUMIST TO FLUMIST. Narrative updated. Corrected report 06-May-2014: This case has been updated with full data due to KUR term additions for FLUMIST/Q/Laiv.
Age: 3.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning a 3 year old, female subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT (Intranasal) started on an unknown date. The patient received expired FLUMIST QUADRIVALENT on 14-Jan-2014 as expiry of vaccine was on 13-Jan-2014. The outcome of the event of expired FLUMIST QUADRIVALENT administered is unknown. The report was considered to be non-serious by reporting health professional. Follow-up of insignificant information received by AstraZeneca/MedImmune on 13-May-2013 from Health Professional: Initial AZ date corrected. Corrected report 04-Apr-2014: Formulation corrected.
Sex: U
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A spontaneous report has been received from a Physician concerning, subject of unknown gender, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT (Intranasal) started on an unknown date. The patient reported received expired FLUMIST which started during 2014. The outcome of the event of received expired FLUMIST is unknown. The report was considered to be non-serious by the reporter.
Age: 18.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A spontaneous report has been received from a Health Professional concerning a patient, male subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT (Intranasal) started on an unknown date. The patient reported expired FLUMIST QUADRIVALENT administered. The outcome of the event of expired FLUMIST QUADRIVALENT administered is unknown. The report was considered to be non-serious by the reporter. Summary of follow-up information received by AstraZeneca/MedImmune on 05-Feb-2014 from Health Professional: AZ received date in first version was changed. Reporter tab updated.
Sex: U
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A spontaneous report has been received from a Physician concerning, subject of unknown gender, who had been receiving FLUMIST (Intranasal). FLUMIST (Intranasal) started on an unknown date. The patient reported RECEIVED EXPIRED FLUMIST which started during 2014. The outcome of the event of RECEIVED EXPIRED FLUMIST is unknown. The report was considered to be non-serious by the reporter.
Age: 2.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A spontaneous report has been received from a Health Professional concerning a patient, male subject, who had been receiving Nasal FLUMIST QUADRIVALENT INTRANASAL started on an unknown date. The patient reported expired FLUMIST QUADRIVALENT administered. The outcome of the event of expired FLUMIST QUADRIVALENT administered is unknown. The report was considered to be non-serious by the reporter.
Age: 13.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a Health Professional concerning a patient, male subject, who had been receiving FLUMIST (Intranasal). FLUMIST started on 23-Jan-2013. It was reported that the patient was administered expired FLUMIST. The outcome of the event of EXPIRED FLUMIST ADMINISTERED is unknown. The report was considered to be non-serious. Corrected report 02-Apr-2014: The field new valid case is ticked as No.
Age: 50.0
Sex: F
Vaccine: FLUN4
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: A report has been received from a Health Professional concerning a 50 year old, female subject, who had been receiving Nasal FLUMIST QUADRIVALENT. The patient's concurrent disease(s) included Type II diabetes. Concomitant medications included amoxicillin, ciprofloxacin, clindamycin, nitrofurantoin, sulfamethoxazole, trimethoprim and phenazopyridine hydrochloride. FLUMIST QUADRIVALENT started on 13-Jan-2014. The patient was 50.5 years old when she received FLUMIST QUADRIVALENT which started on 13-Jan-2014. The outcome of the event of administration to 50.5 year old is unknown. The report was considered to be non-serious by the reporter.
Age: 10.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired drug administered
Clinical narrative: A report has been received from a health professional concerning a 13 year old, male patient who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT (Intranasal) was administered on 17-Jan-2014. The health professional reported administration of expired FLUMIST QUADRIVALENT as expiration date of the drug was 13-JAN-2014. FLUMIST QUADRIVALENT (Intranasal) was discontinued on 17-Jan-2014. The outcome of the event of expired FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious by the reporter.